|
| 37846799 | Indeterminate pulmonary nodules in non-rhabdomyosarcoma soft tissue sarcoma: A study of the European paediatric Soft Tissue Sarcoma Study Group. | Cancer | 2024 |
| 36440693 | Malignant ectomesenchymoma in children: The European pediatric Soft tissue sarcoma Study Group experience. | Pediatr Blood Cancer | 2023 |
| 37920695 | Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives. | Cancer Manag Res | 2023 |
| 37084075 | Metastatic adult-type non-rhabdomyosarcoma soft tissue sarcomas in children and adolescents: A cohort study from the European paediatric Soft tissue sarcoma Study Group. | Cancer | 2023 |
| 37243410 | Intra-abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience. | Pediatr Blood Cancer | 2023 |
| 36094298 | Rhabdomyosarcoma with unknown primary tumor site: A report from European pediatric Soft tissue sarcoma Study Group (EpSSG). | Pediatr Blood Cancer | 2022 |
| 35841307 | Epithelioid hemangioendothelioma in children: The European Pediatric Soft Tissue Sarcoma Study Group experience. | Pediatr Blood Cancer | 2022 |
| 36522207 | Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. | Lancet | 2022 |
| 36176694 | Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). | Cancer Manag Res | 2022 |
| 35863108 | Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. | Eur J Cancer | 2022 |
| 34050156 | Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. | Nat Commun | 2021 |
| 34500044 | Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2021 |
| 34303806 | Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿¿</sup>. | Ann Oncol | 2021 |
| 34214481 | Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). | Lancet Child Adolesc Health | 2021 |
| 34174158 | Facing the challenges of very rare tumors of pediatric age: The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements. | Pediatr Blood Cancer | 2021 |
| 32558231 | Dermatofibrosarcoma protuberans in children and adolescents: The European Paediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). | Pediatr Blood Cancer | 2020 |
| 31952545 | International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours - EURO EWING 2012 Protocol. | Trials | 2020 |
| 32007712 | Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG). | Eur J Cancer | 2020 |
| 32179448 | Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy. | Eur J Cancer | 2020 |
| 30954717 | Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials. | Eur J Cancer | 2019 |
| 31241238 | Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study. | Pediatr Blood Cancer | 2019 |
| 31553693 | High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. | J Clin Oncol | 2019 |
| 31524334 | Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma. | Pediatr Blood Cancer | 2019 |
| 29115724 | Malignant peripheral nerve sheath tumor: The need to get it right first time around. | Pediatr Blood Cancer | 2018 |
| 30188789 | High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. | J Clin Oncol | 2018 |
| 30285218 | Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 |
| 29533008 | Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience. | Cancer Med | 2018 |
| 29286582 | Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005). | Pediatr Blood Cancer | 2018 |
| 28012233 | Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco-regional lymph nodes that responded to chemotherapy. | Pediatr Blood Cancer | 2017 |
| 30169184 | The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series. | Lancet Child Adolesc Health | 2017 |
| 28391003 | Surgery alone is sufficient therapy for children and adolescents with low-risk synovial sarcoma: A joint analysis from the European paediatric soft tissue sarcoma Study Group and the Children's Oncology Group. | Eur J Cancer | 2017 |
| 27082136 | Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005. | Eur J Cancer | 2016 |
| 27777717 | Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English National Cancer Registry: 1985-2009. | Clin Sarcoma Res | 2016 |
| 27176931 | Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. | Eur J Cancer | 2016 |
| 27148438 | UK guidelines for the management of bone sarcomas. | Clin Sarcoma Res | 2016 |
| 27315524 | The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. | Clin Sarcoma Res | 2016 |
| 27569442 | Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. | Lancet Oncol | 2016 |
| 26849118 | Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. | Eur J Cancer | 2016 |
| 25488687 | Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). | Ann Oncol | 2015 |
| 26304893 | Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. | J Clin Oncol | 2015 |
| 26271204 | Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial. | Eur J Cancer | 2015 |
| 26033801 | Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. | J Clin Oncol | 2015 |
| 23274383 | Inflammatory myofibroblastic tumors following the treatment of malignancy in childhood: case reports. | J Pediatr Hematol Oncol | 2014 |
| 24982464 | Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. | J Clin Oncol | 2014 |
| 24041875 | Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report. | Eur J Cancer | 2014 |
| 23480944 | Granular hemostat deposits mimicking disseminated malignancy. | J Pediatr Surg | 2013 |
| 23857870 | Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups. | Pediatr Blood Cancer | 2013 |
| 23816299 | Extracranial rhabdoid tumours: what we have learned so far and future directions. | Lancet Oncol | 2013 |
| 22322070 | Synovial sarcoma in children and adolescents: a critical reappraisal of staging investigations in relation to the rate of metastatic involvement at diagnosis. | Eur J Cancer | 2012 |
| 23143769 | Rare cancers in children - The EXPeRT Initiative: a report from the European Cooperative Study Group on Pediatric Rare Tumors. | Klin Padiatr | 2012 |